Ginkgo Bioworks Holdings Inc
NYSE:DNA

Watchlist Manager
Ginkgo Bioworks Holdings Inc Logo
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Watchlist
Price: 7.31 USD -15% Market Closed
Market Cap: 384.4m USD
Have any thoughts about
Ginkgo Bioworks Holdings Inc?
Write Note

Net Margin
Ginkgo Bioworks Holdings Inc

-487.1%
Current
-416%
Average
4.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-487.1%
=
Net Income
-897.7m
/
Revenue
184.3m

Net Margin Across Competitors

Country US
Market Cap 384.4m USD
Net Margin
-487%
Country US
Market Cap 97.9B USD
Net Margin
11%
Country JP
Market Cap 11.2T JPY
Net Margin
21%
Country US
Market Cap 70.4B USD
Net Margin
13%
Country CH
Market Cap 35.4B CHF
Net Margin
15%
Country US
Market Cap 34.8B USD
Net Margin
7%
Country CN
Market Cap 245.1B CNY
Net Margin
9%
Country CH
Market Cap 27.3B EUR
Net Margin
20%
Country US
Market Cap 28.7B USD
Net Margin
8%
Country IN
Market Cap 2.4T INR
Net Margin
14%
Country DK
Market Cap 165.6B DKK
Net Margin
17%

Profitability Report

View the profitability report to see the full profitability analysis for Ginkgo Bioworks Holdings Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-487.1%
=
Net Income
-897.7m
/
Revenue
184.3m
What is the Net Margin of Ginkgo Bioworks Holdings Inc?

Based on Ginkgo Bioworks Holdings Inc's most recent financial statements, the company has Net Margin of -487.1%.